These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32768954)

  • 21. Pharmacokinetics of intravenous peramivir in the airway epithelial lining fluid of healthy volunteers.
    Funatsu Y; Tasaka S; Asami T; Namkoong H; Fujiwara H; Iketani O; Yagi K; Kimizuka Y; Ishii M; Nishimura T; Ogata H; Iwata S; Betsuyaku T; Hasegawa N
    Antivir Ther; 2016; 21(7):621-625. PubMed ID: 27694694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
    Adjei A; Sundberg D; Miller J; Chun A
    Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
    Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
    Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.
    Sidwell RW; Smee DF
    Expert Opin Investig Drugs; 2002 Jun; 11(6):859-69. PubMed ID: 12036429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peramivir for Influenza A and B Viral Infections: A Pharmacokinetic Case Series.
    Cies JJ; Moore WS; Enache A; Chopra A
    Pharmacotherapy; 2019 Nov; 39(11):1060-1065. PubMed ID: 31514223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of peramivir in healthy volunteers and influenza patients.
    Matsuo Y; Ishibashi T; Hollister AS; Wajima T
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6755-62. PubMed ID: 26282420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
    Sakagami M; Kinoshita W; Sakon K; Makino Y
    Arch Toxicol; 2003 Jun; 77(6):321-9. PubMed ID: 12799771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peramivir for the treatment of influenza.
    Shetty AK; Peek LA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peramivir (Rapivab): an IV neuraminidase inhibitor for treatment of influenza.
    Med Lett Drugs Ther; 2015 Feb; 57(1461):17-9. PubMed ID: 25629811
    [No Abstract]   [Full Text] [Related]  

  • 32. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
    Whitley R; Laughlin A; Carson S; Mitha E; Tellier G; Stich M; Elder J; Alexander WJ; Dobo S; Collis P; Sheridan WP
    Antivir Ther; 2015; 20(7):709-19. PubMed ID: 25318121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits].
    Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR
    Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol.
    Raleigh SM; Verschoyle RD; Bowskill C; Pastorino U; Staniforth JN; Steele F; Dinsdale D; Carthew P; Lim CK; Silvester J; Gescher A
    Br J Cancer; 2000 Oct; 83(7):935-40. PubMed ID: 10970697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of SDZ 64-412, a novel antiasthmatic agent, following intravenous, oral, and inhalation dosing in the rat.
    Charnick SB; Yu Z; Athill LV; Karara AH; Tse FL; Lau DT
    Biopharm Drug Dispos; 1994 May; 15(4):317-27. PubMed ID: 8068869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration.
    Scheetz MH; Griffith MM; Ghossein C; Hollister AS; Ison MG
    Ann Pharmacother; 2011 Dec; 45(12):e64. PubMed ID: 22116989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.
    Cass LM; Efthymiopoulos C; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetic properties of bifenthrin in the rat following multiple routes of exposure.
    Gammon D; Liu Z; Chandrasekaran A; ElNaggar S
    Pest Manag Sci; 2015 Jun; 71(6):835-41. PubMed ID: 25404011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.